Dr. Mark J. Rivellese, MD

  • Tucker, GA
  • Ophthalmologist
NPI1891798039PAC ID6204853138
Medicare services, 2024
48,269
Medicare patients, 2024
931
Part D claims, 2024
742
Publications
1
Clinical trials
1
Practice address
1462 Montreal W Rd, Tucker, GA 30084
Practice phone
Call (404) 255-9096
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Georgia Retina

Tucker, Georgia

See all 3 affiliations

Find Dr. Rivellese's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mark J. Rivellese is an ophthalmologist in Tucker, Georgia

Dr. Rivellese practices at Georgia Retina in Tucker, Georgia.

Dr. Rivellese's NPI, 1891798039, was assigned on May 23, 2005. Dr. Rivellese graduated from State University of New York at Stony Brook, School of Medicine in 1994. Dr. Rivellese holds Georgia license 050911.

NPI and contact details
Medicare PAC ID
6204853138
NPI enumeration date
May 23, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(404) 255-9096
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
58
Medical school graduation
1994

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mark J. Rivellese practices at Georgia Retina in Tucker, Georgia

Dr. Rivellese's primary practice is Georgia Retina, at 1462 Montreal W Rd, Tucker, GA 30084 in Dekalb County. The practice phone is (404) 255-9096.

  • Georgia Retina
    1462 Montreal W Rd, Tucker, GA 30084 · Dekalb CountyPhone(404) 255-9096

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Mark J. Rivellese is affiliated with 2 sites of care and 1 medical group

Dr. Rivellese's primary practice is Georgia Retina in Tucker, Georgia. Dr. Rivellese is also affiliated with Northside Hospital Atlanta. Dmand AI also links Dr. Rivellese to 1 more medical group, named with a free account.

See all 3 affiliations for Dr. Rivellese

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mark J. Rivellese's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rivellese practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Georgia RetinaAvailable with a free account
+1 more site and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Rivellese practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mark J. Rivellese is one of 484 ophthalmologists in Georgia

Ophthalmology is Dr. Rivellese's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rivellese is licensed in Georgia.

Specialties and state licenses

  • Ophthalmology, GeorgiaPrimaryLicense 050911 · taxonomy 207W00000X

Ophthalmologists near Dr. Rivellese

Counts of ophthalmologists with a Dmand AI profile, by place and practice. Each opens the list.

484ophthalmologists in Georgia
3ophthalmologists in Tucker

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mark J. Rivellese billed Medicare for 48,269 services in 2024

CMS data shows 48,269 Medicare services from Dr. Rivellese across 16 procedure codes in 2024, for 931 Medicare patients. Medicare paid $2,352,213 for them.

Medicare services, 202448,269
Medicare patients931
Paid by Medicare$2.4M
Procedure codes16

Dr. Rivellese's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 23,7542024: 43,22482%
Tests and treatments
2023: 3,4372024: 3,5002%
Surgery
2023: 1,3352024: 1,3072%
Office and hospital visits
2023: 1142024: 12711%
Imaging
2023: 712024: 11156%

Where Dr. Rivellese's Medicare services took place, 2024

  • In an office48,255100%
  • In a facility140%

Dr. Rivellese compared with the Georgia median for ophthalmologists, 2024

  • Dr. Rivellese
  • Georgia median
Medicare services
48,269vs 1,58630.4 times
Medicare patients
931vs 57263% above
Part D claims
678vs 89124% below

Medians across 477 ophthalmologists in Georgia with Dmand AI profiles that report each measure.

Dr. Rivellese's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Rivellese

Need commercial claims for Dr. Rivellese?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rivellese and other ophthalmologists in Georgia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mark J. Rivellese treated 931 Medicare patients in 2024, average age 77

CMS counts 931 Medicare patients who saw Dr. Rivellese in 2024. The largest group is 65 to 74, with 398 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rivellese's median patient age at 72, with 57% women.

Medicare patients, 2024931
Average age77
Average risk score1.28
Also on Medicaid5%

Dr. Rivellese's Medicare patients by age, 2024

Dr. Rivellese's Medicare patients by sex, 2024

  • Women52056%
  • Men41144%

Chronic conditions among Dr. Rivellese's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure72%
  3. Arthritis39%
  4. Diabetes28%
  5. Ischemic heart disease26%
  6. Chronic kidney disease24%
  7. Anxiety17%
  8. Atrial fibrillation17%

Share of Medicare patients with each condition. A patient can have several.

Dr. Rivellese's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women57%
  • Men42%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mark J. Rivellese wrote 742 Medicare Part D claims in 2024

In 2024, Dr. Rivellese wrote 742 Medicare Part D claims for 220 patients. 62% of them were for generic drugs. CMS names the drug for 678 of them, across 18 drugs with 11 or more claims each, at $46,103 in total drug cost. In 2023, CMS named 647 claims across 15 drugs.

Part D claims, 2024742
Drugs named by CMS18
Total drug cost$46,103
Part D patients220

Dr. Rivellese's Part D claims by kind of drug, 2024

  • Generic463 claims62%
  • Brand-name279 claims38%

Dr. Rivellese's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Rivellese's Part D claims, 2024

  • Opioids2%15 of 742 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 6472024: 6785%

Drugs named by CMS: 18 in 2024, 15 in 2023.

See all prescribing by Dr. Rivellese

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mark J. Rivellese scored 95 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Rivellese for performance year 2024, reported through an alternative payment model (APM). Dr. Rivellese accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Rivellese's MIPS scores, performance year 2024

  • 95of 100Final score
  • 80.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find ophthalmologists like Dr. Rivellese by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mark J. Rivellese has 1 publication on record

Dmand AI links 1 paper to Dr. Rivellese in 2017.

Papers1

Recent publications by Dr. Rivellese

See all 1 publications and co-authors

See who Dr. Rivellese researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rivellese works with, so you can find a warm path to the right ophthalmologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mark J. Rivellese has worked on 1 clinical trial

Dmand AI links Dr. Rivellese to 1 clinical trial. Conditions studied include Geographic Atrophy and Macular Degeneration. Open Payments lists research payments to Dr. Rivellese that name 1 trial.

Conditions in Dr. Rivellese's trials

  • Geographic Atrophy
  • Macular Degeneration

Investigators on the most trials with Dr. Rivellese

Recent clinical trials with Dr. Rivellese

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Mark J. Rivellese received $43,208 in industry payments from 2016 to 2025

CMS Open Payments shows 280 general payments to Dr. Rivellese from 22 drug and device companies from 2016 to 2025. Ownership or investment make up the largest share, 67% of the total. US Retina LLC paid the most, $28,868. It also lists 55 research payments totaling $69,676 from 2016 to 2018, naming 1 clinical trial.

General payments to Dr. Rivellese by program year, 2016 to 2025

General payments to Dr. Rivellese by kind, 2016 to 2025

$43.2Kin total
  • Ownership or investment$28,86867%
  • Food and beverage$13,87532%
  • Travel and lodging$3851%
  • Education$420%
  • Entertainment$380%

Companies that paid Dr. Rivellese the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Rivellese

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mark J. Rivellese graduated from State University of New York at Stony Brook, School of Medicine

Dr. Rivellese graduated from State University of New York at Stony Brook, School of Medicine in 1994.

  1. Medical schoolState University of New York at Stony Brook, School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Mark J. Rivellese's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mark J. Rivellese

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mark J. Rivellese's NPI number?

Dr. Mark J. Rivellese's NPI number is 1891798039. It was assigned on May 23, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Mark J. Rivellese?

Dr. Mark J. Rivellese is an ophthalmologist in Tucker, Georgia. The primary specialty in the NPI Registry is Ophthalmology Physician (taxonomy code 207W00000X).

Where does Dr. Mark J. Rivellese practice?

Dr. Rivellese practices at 1462 Montreal W Rd, Tucker, GA 30084. Dr. Rivellese's primary practice is Georgia Retina in Tucker, Georgia. Dmand AI also links Dr. Rivellese to 1 medical group.

What is Dr. Mark J. Rivellese's office phone number?

The practice phone on file for Dr. Rivellese is (404) 255-9096.

What is Dr. Mark J. Rivellese's medical license number?

Dr. Rivellese holds Georgia license 050911.

Which hospitals is Dr. Mark J. Rivellese affiliated with?

Dr. Rivellese is affiliated with Northside Hospital Atlanta.

Does Dr. Mark J. Rivellese accept Medicare?

Yes. CMS data shows Dr. Rivellese billed Medicare for 48,269 services in 2024, and Dr. Rivellese accepts Medicare assignment.

What is Dr. Mark J. Rivellese's MIPS score?

Dr. Rivellese's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Mark J. Rivellese see?

CMS counts 931 Medicare patients who saw Dr. Rivellese in 2024, with an average age of 77.

What services does Dr. Mark J. Rivellese bill to Medicare?

In 2024, Dr. Rivellese's most billed Medicare services were injected or infused drug (J2777), eye exam or test (92134) and surgery: eye (67028).

Show 5 more questionsShow fewer questions

Where did Dr. Mark J. Rivellese go to medical school?

Dr. Rivellese graduated from State University of New York at Stony Brook, School of Medicine in 1994.

What drugs does Dr. Mark J. Rivellese prescribe most?

In 2024 Medicare Part D data, Dr. Rivellese's most prescribed drugs by claims were Prednisolone Acetate, Ketorolac Tromethamine and Timolol Maleate.

Has Dr. Mark J. Rivellese received payments from drug or device companies?

CMS Open Payments shows $43,208 in general payments to Dr. Rivellese from 22 companies from 2016 to 2025. The largest total came from US Retina LLC.

How long has Dr. Mark J. Rivellese been practicing?

Dr. Rivellese graduated from medical school in 1994, 32 years ago.

Does Dr. Mark J. Rivellese do research?

Dmand AI links 1 publication to Dr. Rivellese. Dr. Rivellese has worked on 1 clinical trial.

Selling to ophthalmology practices?

See ophthalmologists in Georgia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)